Search

Author/Creator Nguyen, Allison Martin

3. Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials. Issue 10328 (5th March 2022)

Authors:
McGarvey, Lorcan P; Birring, Surinder S; Morice, Alyn H; Dicpinigaitis, Peter V; Pavord, Ian D; Schelfhout, Jonathan; Nguyen, Allison Martin; Li, Qing; Tzontcheva, Anjela; Iskold, Beata; Green, Stuart A; Rosa, Carmen La; Muccino, David R; Smith, Jaclyn A
Journal:
Lancet
Issue:
Volume 399:Issue 10328(2022)
Page Start:
909
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗